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I. INTRODUCTION
Nanobiotechnology promises a wide variety of medical
applications. Some of the proposed applications include more
efficient and specific drug delivery, systems microsurgic devices that
find and destroy viruses or cancer cells, and inexpensive and high
throughput diagnostic devices. If nanobiotechnology can fulfill its
promises, its impact on society and market will be profound. One
optimistic industry report projects that nanobiotechnology will have
an overall market impact of nearly $300 billion within the next 12
years.1  Motivated by the commercial implications, business
executives, industrial research scientists and venture capitalists are
quickly moving nanotechnology research from academic laboratories
into industrial research programs.2  In some areas, industrial
researchers are pursuing research that may lead to commercial
products in the near future. Despite its potential impact on the
society, ethical issues related to nanobiotechnology are not well
understood, particularly by the industrial decision-makers.
II. WHAT iS NANOBIOTECHNOLOGY?
For a meaningful discussion of the legal and ethical implications
of an emerging technology, it would be helpful to have a working
definition of the underlying technology. While all emerging
technologies tend to be difficult to define, nanotechnology is a rare
t The author has a Ph.D and J.D., and wishes to thank Doris Chen and Alok Goel for
their helpful discussion and Priya Rath for reviewing and editing this Article.
1. Mehr, Nanobiotechnology, D&MD Executive Briefing (2002), available at
http://www.bioportfolio.com/cgi-bin/acatalog/9072_toc.pdf.
2. Companies that may be conducting nanotechnology research include Aclara, Arryx,
Caliper, Carbon Nanotechnologies, Cell Robotics International, EngeneOS, Fluidigm, Gyros,
HandyLab, Life Sensors, Luna nanoMaterials, MemGen, Metrigenix, MicroCHIPS, Micronics,
NanoBio, Nano-C, NanoCarrier, Nanogem, Nanoprobe, Nanospectra, NanoSphere, Nanostream,
Ntera, Quantum Dot, SurroMed, Targetsome, U.S. Genomics, etc. See id.
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field that has "produced so much confusion.",
3
"Nanotechnology" has become a buzz word for the science and
technology pertaining to visualization, manipulation, and control of
materials at the nanometer scale.4 A nanometer is one billionth of a
meter. An atom is about one third of a nanometer wide.
According to one definition, nanotechnology focuses on a scale.5
This is a very unusual definition of a technology field because other
technologies tend to be defined by a key technology or breakthrough.
For example, microelectronic technology is powered by
photolithographic manufacturing of integrated circuits; genetic
engineering technology is based upon recombinant DNA; and the
Internet is enabled by packet switching network/networking
protocols/ample supply of computers, and made popular by the World
Wide Web. In fact, nanotechnology, according to various definitions,
may encompass many technologies that can operate on the nanometer
scale. The broadness in scope presents difficulties for understanding
the legal and ethical implications of nanotechnology because
nanotechnology may represent a collection of technologies, each of
which may have different characteristics and applications.
Some ethical discussions have been focused on the field of
molecular nanotechnology.6 Technologies related to the mechanical
control over the arrangement of atoms are often referred to as
molecular nanotechnology. American physicist and Nobel Laureate
Richard Feynman7 introduced the concept of manipulating matter on
an atomic scale and its implications in his classic talk at the American
Physical Society's 1959 annual meeting.8 Additionally, physicist K.
3. Jeffrey M. Perkel, Nanotech Dreams, THE SCIENTIST, March 1, 2002 at
http://www.the-scientist.com/yr2002/mar/profile_020304.html (last visited Apr. 20, 2003).
4. Id.; Drexler, Introduction to Nanotechnology in Prospects, in NANOTECHNOLOGY:
TOWARD MOLECULAR MANUFACTURING I (Markus Krumenacker & James Lewis eds., 1995).
5. See, e.g., Perkel, supra note 3 (quoting Chad A. Mirkin, George B. Rathman
Professor of chemistry and director of Institute of Nanotechnology at the Northwestern
University. "It is a field that focuses on a scale rather than a material. So, it affects
everything.").
6. See, e.g., Frederick A. Fiedler & Glenn H Reynolds, Legal Problems of
Nanotechnology: An Overview, 3 S. CAL. INTERDISC. L. J. 593 (1994); David D. Friedman,
Future Imperfect (Oct. 6, 2002) (draft), at
http://www.daviddfriedman.com/future imperfect draft/future-imperfect.html.
7. Richard Feynmann shared the 1965 Nobel Prize in Physics with Sin-Itiro Tomonaga
and Julian Schwinger "for their fundamental work in quantum electrodynamics, with deep-
ploughing consequences for the physics of elementary particles." See The Nobel Prize in
Physics 1965, Nobel e-museum, at http://www.nobel.se/physics/laureates/1965/index.html (last
modified June 16, 2000).
8. Richard Feinman, There is Plenty of Room at the Bottom, ENGINEERING AND
ETHICS OF NANOBIOTECHNOLOGY
Eric Drexler contributed significantly to the theoretical thinking about
molecular nanotechnology. Drexler proposed the concept of
"assemblers" which are molecular machines that are capable of
building other molecular machines. 9 He also suggested "replicators"
which are assembler-like devices that could create exact copies of
themselves. Such replicators may enable inexpensive mass
production of any device. However, not all scientists view the future
in the same way as Drexler. For example, Nobel laureate Richard E.
Smalley once declared that Drexler's devices "will never become
more than a futuristic daydream." 10
While it is still not possible to control and manipulate matter on
an atomic scale at will, recent scientific discoveries suggest that
certain rearrangement of atoms are achievable and may offer practical
applications. For example, new forms of the element carbon-called
fullerenes- can be produced by vaporizing carbon condenses in an
atmosphere of inert gas to form the soccer-ball-like fullerenes
arrangement of carbon atoms. In addition, it has been possible to
produce thin tubes with closed ends, nanotubes, arranged in the same
way as fullerenes. The new materials are the basis of much of the
emerging nanotechnology industry. 1
Nanobiotechnology is the application of nanotechnology to the
life sciences and may include the application of biotechnology to
nanotechnology (e.g., using biological means to manipulate materials
on the nanometer scale). Many areas of biomedical applications have
been suggested. At a conference organized by National Institutes of
Health's Bioengineering Consortium, the following areas were
identified for research in the coming years: synthesis and use of
nanostructures; applications of nanotechnology in therapy;
biomimetic nanostructures, which are synthetic products developed
from an understanding of biological systems; biological
nanostructures; electronic biological interface; devices for early
detection of diseases; instruments for studying individual molecules;
and nanotechnology for tissue engineering.12
SCIENCE, February 1960, at http://www.zyvex.com/nanotech/feynman.html.
9. See K. ERIC DREXLER, ENGINES OF CREATION-THE COMING ERA OF
NANOTECHNOLOGY (1986).
10. R.E. Smalley, Of Chemistry, Love and Nanobots, SCIENTIFIC AMERICAN, Sept. 2001,
at 285.
11. PETER HARRIS, CARBON NANOTUBES AND RELATED STRUCTURES: NEW MATERIALS
FOR THE TWENTY-FIRST CENTURY (Cambridge University Press 2000).
12. Malsch, Biomedical Applications of Nanotechnology, THE INDUSTRIAL PHYSICIST,
June/July 2002, at 15.
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In the diagnostic area, much of the research has been focused on
biochips, which are devices that contain many biological sensors.'
3
Nanotechnology has been proposed to increase the density of sensors
on the biochips14 and to provide alternative detection mechanisms."
In the therapeutic advances, one potential near term application may
be in drug delivery. Many researchers are working on using
nanoparticles as vehicles for efficient drug delivery. 16 From a long
term prospective, some researchers envision nanorobotics that are
capable of navigating throughout the body, repairing injuries,
destroying tumors and even performing gene therapy.'
7
A. Ethical Issues and Nanobiotechnology
There are at least two important reasons for discussing ethical
issues at this early stage of technology development. One is to
anticipate ethical problems such as "preventable harms, conflicts
about justice and fairness, and issues concerning respect for persons
likely to arise from specific nano initiatives."' 8 The second aim is "to
foster sensitivity to ethical issues and responsibility at every level of
decision making by both technical and policy people."' 9
Despite the great interest in understanding the legal and ethical
implications of nanobiotechnology, there seems to be a lag in ethics
research in nanotechnology. 20 There are significant research funds
available for studying the ethics of nanotechnology. Unfortunately,
as Mynyusiwall et al. recently reported, research funds have not been
spent and ethics publications are lagging behind the science." For
example, the National Nanotechnology Initiative allocated $16 -28
13. See generally Perkel, supra note 3.
14. R. Piner, J. Zhu, F. Xu, S. Hong, C. A. Mirkin, 'Dip-pen' Nanolithography, 283 SC.
661 (1999).
15. See, e.g., Quantum Dot Corporation website, at http://www.quantumdot.com;
Nanotheraputics website at http://www.nanosphere.com.
16. See Celia M. Henry, Drug Delivery, 80(34) C&E NEWS 39 (2002), at
http://pubs.acs.org/cen/coverstory/8034/8034drugdelivery.html; Majeti N. V. Ravi Kumar, Nano
and Microparticles as Controlled Drug Delivery Devices, 3(2) J. PHARM. PHARMACEUT. SCI.
234 (2000), at http://www.ualberta.ca/-csps/JPPS3(2)/M.Kumar/particles.htm.
17. Perkel, supra note 3.
18. V. Weil, Ethical Issues in Nanotechnology, in SOCIETAL IMPLICATIONS OF
NANOSCIENCE AND NANOTECHNOLOGY 193 (M. Roco & W.S. Bainbridge eds., National
Science Foundation 2001).
19. Id.
20. Mnyusiwalla, et al., 'Mind the Gap': Science and Ethics in Nanotechnology, NANO
TECHNOLOGY 14:R9-R13, available at
http://www.utoronto.ca/jcb/pdf/nanotechnology_paper.pdf (Feb. 17, 2003).
21. Id.
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million to study societal implications, but less than half of the amount
was spent.22 The National Science Foundation did not award a single
project proposing to study the social impact of nanotechnology, even
though it was charged with the responsibility to spend $8 million in
this research area. Apparently, no one submitted a meritorious
research grant proposal.
While anticipating all the ethical issues arising from
nanotechnology and its application is difficult, some ethical issues are
so commonplace in any emerging technology that we can safely
assume that we will encounter the same issues for nanotechnology.
Such areas include environment and safety, equity, and potential
conflict of interest arising from the interactions among government,
industry, and universities, and intellectual property ownership.
Additionally, as expected, we are seeing increasingly critical
examinations concerning the safety of nanotechnology in terms of
material toxicity and potential harm to the environment.23 Small
nanoparticles may enter the human body but the health implications
are yet unknown. In the nanobiotechnology area, the public may have
legitimate reasons to be concerned about the safety of employing
viruses as nanotechnology tools. Also, because of the short history of
nanotechnology and its unparalleled power, we should be particularly
concerned about any unforeseen adverse effects.
The lack of meritorious ethics research proposals may be related
to the difficulty in identifying or anticipating ethical issues that are
unique to nanobiotechnology, particularly its near term applications.
Some researchers have examined the social implications of distant
and controversial molecular nanotechnology. 24  However, the focus
on the futuristic world of molecular nanotechnology has also been
criticized for illogically extrapolating current research.25
22. Id.
23. Robert A. Freitas Jr., Could Medical Nanobots be Carcinogenic?, IMM REPORT
NUMBER 33: NANOMEDICINE (2002), available at http://www.imm.org/Reports/Rep033.html
(last updated Oct. 29, 2002).
24. For those who are interested in the world of assemblers and replicators, visit Prof.
Friedmann's web site at http://www.daviddfriedmann.com; see also Bill Joy, Why the Future
Doesn't Need Us, WIRED MAGAZINE, Apr. 2000, at
http://www.wired.com/wired/archive/8.04/joy.html.
25. Stanford Biophysicist Steven Block was quoted as saying, "Nobody has a clue how to
build a nanoassembler, much less get one to reproduce." Gary Stix's view may represent the
critics. He stated in a special issue of Scientific American on Nanotechnology (NT) that "there
has emerged a cult now of futurists who foresee NT as a pathway to a technological utopia:
unparallel prosperity, pollution free industry, even something resembling eternal life." Robert
F. Service, Is Nanotechnology Dangerous?, SCIENCE, November 24, 2000, at 1526.
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Nevertheless, the potential social implications of assemblers and
replicators are fascinating areas. The intellectual discussion about
assemblers and replicators in the futuristic nanoworld may offer
insights in many areas including ethics of near-term nanotechnology.
On the other hand, focusing on the ethics discussion on the long-term
potentials is not enough. Ethics discussion about near-term
applications is clearly needed to guide further development of
nanotechnology applications. Ethics researchers and legal scholars
should be encouraged to study the many ethics issues arising from the
near term nanotechnology research and commercialization.
Next, two examples will be used to illustrate some of the ethical
questions we may face in the near term. The first example is a
nanotechnology-powered era of personal genomics. The second
example is the issue related to the patenting of nanotechnology.
1. Nanotechnology-Powered Personal Genomics
Many nanotechnology companies currently are focusing their
research on developing more efficient and inexpensive genetic
analysis devices. The experience of the microarray industry may
provide a glance of what nanotechnology can do to change the way
genetic information is obtained. In the last decade, microarray
technology particularly, photolithographic, or combinatorial synthesis
of genetic probes, has greatly advanced the acquisition of genetic
information by shrinking the feature size of genetic probes.26 For
commercially available GeneChip® probe arrays, each of the genetic
probes on a microarray occupies a feature of eighteen microns.
Hundreds of thousands of probes may be synthesized on a single chip
to interrogate a large amount of genetic information.
Nanotechnology promises even smaller feature sizes and much
higher densities of probes. If the probe feature size can be reduced to
the nanometer scale, a small glass slide containing billions of probes
can be potentially manufactured at a low cost. Such slides can be
used to interrogate the entire human genome in a single assay. While
there are many manufacturing, biochemical, software, and detection
technology obstacles to overcome before the nanobiochip becomes a
reality, it is closer to reality than many believe. If nanomicroarrays
become a reality, the social implications may be profound. What
nanomicroarrays can potentially do is to make genomic information
readily available to the majority of the population at a very low cost,
26. See Affymetrix website, at http://www.affymetrix.com.
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thus making genomic information ubiquitous. This raises the
following questions: Will the technologies that can make genomic
information ubiquitous, change the societal view on privacy and other
ethics concerns? Will there be a division between genomic
information haves and have-nots? Will genetic discrimination be of a
concern if it turns out that no one has a perfect genome (i.e. everyone
has a set of bad genes)? Will the development of personal genomic
technology profoundly change the way we interact with each other?
These issues need to be discussed so that ethics become a part of the
decision matrix for many research and commercialization decisions
on the pathway to the era of a nano-powered personal genomics.
2. Intellectual Property and Freedom to Operate
Universities and private research organizations are patenting
nanotechnology at an increasing rate. According to a Derwent ITP
survey, in 2000 alone, there were 1200 patents covering various
aspects of nanotechnology.27 Therefore, another issue that the
fledging nanotechnology industry may soon face is how to maintain
freedom of operation for a large number of innovators, while
rewarding innovations with patent rights.
There are a number of reasons why freedom to operate can be a
serious problem for the fledging nanotechnology industry.
Nanotechnology has become a high visibility technology that is
pursued in a large number of academic and industrial laboratories,
which may result in a large number of patent owners, each having
some right to exclude others from practicing various aspects of the
technology. In addition, patents that cover traditional products may
also contain generic claims covering the product concept, not limited
by the scale and manufacturing technology. Such patent claims will
cover nanotechnology products as well. As a result, for an entity to
commercialize a nanotechnology product, it may potentially have to
obtain permissions from a large number of patent owners. How
industry and society resolve the freedom to operate problem may be
dependent upon our understanding of many ethical and legal
questions relating to equity and fairness, nondiscriminatory license
practice, incentive to innovation, division and aggregation of legal
rights among other questions.
27. Press Release, Derwent Information, Derwent Responds to Rise in Nanotechnology
Patents with a New Service, at http://www.derwent.com/press/2002/press4.html (March 25,
2002).
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B. Ethical Discussion in Industrial Nanotechnology Research
Decision-Making
As mentioned earlier, the second aim of discussing ethical issues
is to foster sensitivity among executives, research scientists, and other
decision-makers to ethical issues. The second aim is perhaps even
more important than theoretical discussion of the ethical issues a nano
society may face. What ethical issues the society is going to face and
how the society is going to address them may be somewhat dependent
upon how the scientific researchers and executives make decisions on
research and commercialization priorities.
Much of the industrial research and product road maps are kept
confidential and out of the reach of academic social scientists and
philosophers of ethics. The decision makers at the frontline are often
pursuing a particular pathway to products and focusing their attention
on the immediate technical challenges. It is difficult to incorporate
ethical implications in the decision-making processes unless the
decision-makers are thoroughly educated about how to evaluate
ethical issues.
For the publicly supported nanotechnology research programs,
such as the National Nanotechnology Initiative, it may be a good idea
to include social scientists and humanistic scholars in the social
process of setting visions for nanotechnology to ensure that ethical
issues are considered.2 8  This could set a precedent for private
research programs whereas it is much more difficult to incorporate
social scientists in the decision making process.
Some corporations retain ethics advisory boards consisting of
experts who are familiar with ethical issues. The ethics advisory
boards can evaluate major research decisions and should be a great
mechanism to incorporate ethics in the research decision process.
But, it is unlikely that corporate ethics advisory boards will be
involved in the day-to-day decision making process. Therefore, it is
critical to engage research scientists, research managers, corporate
attorneys, and executives in a discussion of potential legal and ethical
issues, so that important issues can be addressed in sync with
scientific research and technology development.
III. CONCLUSION
Nanobiotechnology promises many powerful applications that
may have profound social implications. Ethics research on the
28. Id. at 12.
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nanotechnology applications is needed to provide guidance for the
decision-makers. However, the research on the ethics of
nanotechnology, particularly for the short-term applications, is
lagging behind science. Therefore, it is important to encourage ethics
researchers to produce quality research proposals on ethical issues
and to have the public involved in the discussion of the social impact
of nanotechnology. It is also of critical importance to have the
industrial decision-makers engaged in the ethics discussion so that
ethics consideration will become a part of the often private corporate
research decision-making process.

